Carrera Capital Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$362K Buy
722
+17
+2% +$8.16K 0.05% 156
2026
Q1
$347K Sell
705
-74
-9% -$40.2K 0.05% 131
2025
Q4
$452K Buy
779
+97
+14% +$54.9K 0.08% 104
2025
Q3
$331K Sell
682
-44
-6% -$20.5K 0.06% 108
2025
Q2
$295K Sell
726
-91
-11% -$38K 0.06% 116
2025
Q1
$407K Buy
817
+156
+24% +$84.5K 0.09% 115
2024
Q4
$344K Sell
661
-1,708
-72% -$939K 0.08% 109
2024
Q3
$1.47M Buy
+2,369
New +$1.4M 0.36% 49

Other funds holding TMO

Carrera Capital Advisors's TMO Position: Q2 2026 in Review

Carrera Capital Advisors increased its Thermo Fisher Scientific (TMO) stake by 2.4% in Q2 2026, buying an estimated $8.16K and bringing the position to 722 shares worth $362K. The position accounts for 0.05% of the portfolio, ranked #156.

Carrera Capital Advisors first reported a position in TMO in Q3 2024 and has held it in 8 quarters since. The position peaked at $1.47M in Q3 2024. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Carrera Capital Advisors held 722 shares of Thermo Fisher Scientific worth $362K as of Q2 2026.
  • Carrera Capital Advisors bought 17 Thermo Fisher Scientific shares in Q2 2026, an estimated $8.16K.
  • Thermo Fisher Scientific made up 0.05% of Carrera Capital Advisors's portfolio in Q2 2026, its #156 holding.
  • Carrera Capital Advisors first reported a position in Thermo Fisher Scientific in Q3 2024 and has held it in 8 quarters since.
  • Carrera Capital Advisors's Thermo Fisher Scientific position peaked at $1.47M in Q3 2024.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Carrera Capital Advisors's 13F filing for Q2 2026, filed 3 Aug 2026.